Koyfin Home > Directory > Health Care > Acorda Therapeutics > Total Debt / EBITDA

Acorda Therapeutics Total Debt / EBITDA Chart (ACOR)

Acorda Therapeutics annual/quarterly Total Debt / EBITDA from 2010 to 2020.
  • Acorda Therapeutics Total Debt / EBITDA for the quarter ending June 06, 2020 was $-6m a 14.84% decrease of -1m year over year
  • Acorda Therapeutics Total Debt / EBITDA for the last 12 months ending June 06, 2020 was $-5m a 6.83% decrease of 0m year over year
  • Acorda Therapeutics Annual Total Debt / EBITDA for 2019 was $-4m a 190.75% decrease of -7m from 2018
  • Acorda Therapeutics Annual Total Debt / EBITDA for 2018 was $3m a 24.15% increase of 1m from 2017
  • Acorda Therapeutics Annual Total Debt / EBITDA for 2017 was $2m a -1,035.89% decrease of -26m from 2016
Other Ratios Metrics:
  • Acorda Therapeutics Total Debt / Capital for the quarter ending December 12, 2018 was $36m a -5.79% decrease of -2m year over year
  • Acorda Therapeutics Other Liabilities for the quarter ending December 12, 2018 was $204m a 10.59% increase of 22m year over year
  • Acorda Therapeutics Total Debt / Equity for the quarter ending December 12, 2018 was $56m a -9.35% decrease of -5m year over year
View Chart On Koyfin

Quarterly ACOR Total Debt / EBITDA Data

06/2020$-6m
03/2020$-3m
12/2019$75m
09/2019$-5m
06/2019$-4m
03/2019$-3m
12/2018$-6m
09/2018$2m
06/2018$2m
03/2018$8m

Annual ACOR Total Debt / EBITDA Data

2019$-4m
2018$3m
2017$2m
2016$28m
2015$5m
2014$5m
2013$0m
2012$0m
2011$0m
2010$-2m